Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

113.41 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, May 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗

May 13, 2026

Investors can find much better opportunities.

Via The Motley Fool

Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities

May 13, 2026

Via Investor Brand Network

InvestorNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation

May 13, 2026

Via Investor Brand Network

Merck & Co. Inc. (NYSE:MRK): A High Dividend Rating Backed by Strong Profitability and Financial Health ↗

May 09, 2026

Via Chartmill

Merck (NYSE:MRK) Q1 2026 Results Show Underlying Strength Despite Acquisition-Driven Loss ↗

April 30, 2026

Via Chartmill

Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities

May 13, 2026

From BioMedWire

Via GlobeNewswire

1 Dividend ETF Quietly Outperforming the Market Right Now ↗

May 13, 2026

A lucrative dividend will always attract investors when times are rocky.

Via The Motley Fool

2 Cash-Producing Stocks to Research Further and 1 Facing Challenges

May 13, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...

Via StockStory

Topics Credit Cards

Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026

May 12, 2026

From Merck & Co., Inc.

Via Business Wire

2 Dividend Stocks to Double Up On Right Now ↗

May 08, 2026

They can weather many storms.

Via The Motley Fool

Topics Intellectual Property

Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate

May 07, 2026

From Merck & Co., Inc.

Via Business Wire

Eli Lilly Now Has the World's Best-Selling Drug -- But Does That Make the Stock a No-Brainer Buy? ↗

May 07, 2026

Mounjaro generated $8.66 billion in sales in the first quarter.

Via The Motley Fool

The Top 5 Analyst Questions From Merck’s Q1 Earnings Call

May 07, 2026

Merck’s first quarter results were shaped by robust momentum in its oncology and animal health divisions, as well as meaningful contributions from recent pro...

Via StockStory

Topics Earnings

Merck Animal Health Selects Salesforce’s Agentforce Life Sciences for Customer Engagement to Transform Animal Care and Enhance Support Experiences for Employees

May 06, 2026

From Salesforce

Via Business Wire

Tempus AI (TEM) Q1 2026 Earnings Transcript ↗

May 05, 2026

Tempus AI (TEM) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Artificial Intelligence

Merck Completes Acquisition of Terns Pharmaceuticals, Inc.

May 05, 2026

From Merck & Co., Inc.

Via Business Wire

3 Monster Dividend Stocks That Could Pay You Through the Next Decade of Chaos ↗

May 05, 2026

It's time to start thinking at least a little bit defensively by exchanging long-term potential gains for certain near-term cash flow.

Via The Motley Fool

Topics Artificial Intelligence

What's going on in today's pre-market session: S&P500 movers ↗

May 01, 2026

Via Chartmill

MRK Q1 Deep Dive: Oncology Strength, New Launches, and Pipeline Milestones Define Quarter

May 01, 2026

Global pharmaceutical company Merck (NYSE:MRK) announced better-than-expected revenue in Q1 CY2026, with sales up 4.9% year on year to $16.29 billion. The co...

Via StockStory

Top S&P500 movers in Thursday's after hours session ↗

April 30, 2026

Via Chartmill

Merck (MRK) Q1 2026 Earnings Call Transcript ↗

April 30, 2026

Merck (MRK) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Merck (NYSE:MRK) Surprises With Q1 CY2026 Sales

April 30, 2026

Global pharmaceutical company Merck (NYSE:MRK) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 4.9% year on year to $16....

Via StockStory

Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones

April 30, 2026

From Merck & Co., Inc.

Via Business Wire

Merck (MRK) Q1 Earnings Report Preview: What To Look For

April 28, 2026

Global pharmaceutical company Merck (NYSE:MRK) will be reporting results this Thursday before market open. Here’s what investors should know. Merck beat anal...

Via StockStory

Topics Artificial Intelligence

Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke

April 28, 2026

From Merck & Co., Inc.

Via Business Wire

3 Biotech Stocks That Could Benefit from the Patent Cliff ↗

April 27, 2026

Via MarketBeat

Topics Intellectual Property

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

April 24, 2026

From Merck & Co., Inc.

Via Business Wire

Q4 Earnings Roundup: Merck (NYSE:MRK) And The Rest Of The Branded Pharmaceuticals Segment

April 23, 2026

Let’s dig into the relative performance of Merck (NYSE:MRK) and its peers as we unravel the now-completed Q4 branded pharmaceuticals earnings season. Looking...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Why Merck (MRK) Shares Are Trading Lower Today

April 21, 2026

What Happened? Shares of global pharmaceutical company Merck (NYSE:MRK) fell 3.8% in the afternoon session after the company, along with its partner Eisai, a...

Via StockStory

Topics Government Intellectual Property

FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir)

April 21, 2026

From Merck & Co., Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.